Bontempo Ohly Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.42M | Sell |
45,066
-2,123
| -4% | -$245K | 2.45% | 5 |
|
|
2025
Q4 | $4.97M | Sell |
47,189
-40
| -0.1% | -$3.75K | 2.14% | 8 |
|
|
2025
Q3 | $3.96M | Buy |
47,229
+750
| +2% | +$61.8K | 1.72% | 21 |
|
|
2025
Q2 | $3.68M | Buy |
46,479
+1,893
| +4% | +$150K | 1.67% | 22 |
|
|
2025
Q1 | $4M | Buy |
+44,586
| New | +$4.16M | 1.93% | 21 |
|
|
2024
Q4 | – | Sell |
-1,800
| Closed | -$204K | – | 35 |
|
|
2024
Q3 | $204K | Hold |
1,800
| – | – | 0.09% | 34 |
|
|
2024
Q2 | $223K | Hold |
1,800
| – | – | 0.11% | 34 |
|
|
2024
Q1 | $238K | Sell |
1,800
-2,008
| -53% | -$248K | 0.12% | 33 |
|
|
2023
Q4 | $415K | Sell |
3,808
-325
| -8% | -$33.7K | 0.2% | 31 |
|
|
2023
Q3 | $425K | Sell |
4,133
-5,490
| -57% | -$592K | 0.23% | 31 |
|
|
2023
Q2 | $1.11M | Hold |
9,623
| – | – | 0.54% | 28 |
|
|
2023
Q1 | $1.02M | Sell |
9,623
-19,672
| -67% | -$2.12M | 0.51% | 30 |
|
|
2022
Q4 | $3.25M | Sell |
29,295
-686
| -2% | -$70.1K | 1.93% | 17 |
|
|
2022
Q3 | $2.58M | Sell |
29,981
-140
| -0.5% | -$12.5K | 1.71% | 22 |
|
|
2022
Q2 | $2.75M | Sell |
30,121
-323
| -1% | -$28.6K | 1.7% | 23 |
|
|
2022
Q1 | $2.5M | Buy |
30,444
+1,314
| +5% | +$104K | 1.37% | 25 |
|
|
2021
Q4 | $2.23M | Buy |
29,130
+413
| +1% | +$32.9K | 1.15% | 26 |
|
|
2021
Q3 | $2.16M | Sell |
28,717
-112
| -0.4% | -$8.52K | 1.21% | 27 |
|
|
2021
Q2 | $2.24M | Sell |
28,829
-1,295
| -4% | -$96.3K | 1.22% | 28 |
|
|
2021
Q1 | $2.22M | Buy |
+30,124
| New | +$2.22M | 1.24% | 28 |
|
|
2020
Q1 | – | Sell |
-28,887
| Closed | -$2.51M | – | 37 |
|
|
2019
Q4 | $2.51M | Sell |
28,887
-215
| -0.7% | -$17.7K | 1.67% | 26 |
|
|
2019
Q3 | $2.34M | Buy |
29,102
+41
| +0.1% | +$3.29K | 1.66% | 25 |
|
|
2019
Q2 | $2.33M | Buy |
29,061
+173
| +0.6% | +$13.2K | 1.68% | 23 |
|
|
2019
Q1 | $2.29M | Sell |
28,888
-17,370
| -38% | -$1.3M | 1.66% | 24 |
|
|
2018
Q4 | $3.37M | Buy |
46,258
+770
| +2% | +$54.4K | 2.5% | 7 |
|
|
2018
Q3 | $3.08M | Buy |
45,488
+3,148
| +7% | +$201K | 2.05% | 9 |
|
|
2018
Q2 | $2.45M | Buy |
42,340
+837
| +2% | +$47.2K | 1.92% | 15 |
|
|
2018
Q1 | $2.16M | Sell |
41,503
-59
| -0.1% | -$3.19K | 1.72% | 21 |
|
|
2017
Q4 | $2.18M | Buy |
41,562
+38,010
| +1,070% | +$2.11M | 1.7% | 23 |
|
|
2017
Q3 | $217K | Hold |
3,552
| – | – | 0.17% | 30 |
|
|
2017
Q2 | $217K | Hold |
3,552
| – | – | 0.18% | 30 |
|
|
2017
Q1 | $215K | Sell |
3,552
-59,705
| -94% | -$3.62M | 0.17% | 30 |
|
|
2016
Q4 | $3.55M | Sell |
63,257
-655
| -1% | -$38.3K | 2.9% | 5 |
|
|
2016
Q3 | $3.81M | Buy |
63,912
+58
| +0.1% | +$3.39K | 3.18% | 3 |
|
|
2016
Q2 | $3.51M | Buy |
63,854
+321
| +0.5% | +$17.1K | 3.03% | 5 |
|
|
2016
Q1 | $3.21M | Buy |
63,533
+24,540
| +63% | +$1.2M | 2.82% | 7 |
|
|
2015
Q4 | $1.97M | Buy |
38,993
+568
| +1% | +$28.6K | 1.86% | 11 |
|
|
2015
Q3 | $1.81M | Buy |
38,425
+2,567
| +7% | +$136K | 1.83% | 12 |
|
|
2015
Q2 | $1.95M | Sell |
35,858
-229
| -0.6% | -$12.8K | 1.89% | 11 |
|
|
2015
Q1 | $1.98M | Sell |
36,087
-1,312
| -4% | -$74.3K | 1.88% | 10 |
|
|
2014
Q4 | $2.03M | Buy |
+37,399
| New | +$2.08M | 1.96% | 11 |
|
Other funds holding MRK
VCM
VPM
Bontempo Ohly Capital Management's MRK Position: Q1 2026 in Review
Bontempo Ohly Capital Management reduced its Merck (MRK) stake by 4.5% in Q1 2026, selling an estimated $245K and leaving 45,066 shares worth $5.42M. The position accounts for 2.45% of the portfolio, ranked #5.
Bontempo Ohly Capital Management first reported a position in MRK in Q4 2014 and has held it in 41 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Bontempo Ohly Capital Management held 45,066 shares of Merck worth $5.42M as of Q1 2026.
- Bontempo Ohly Capital Management sold 2,123 Merck shares in Q1 2026, an estimated $245K.
- Merck made up 2.45% of Bontempo Ohly Capital Management's portfolio in Q1 2026, its #5 holding.
- Bontempo Ohly Capital Management first reported a position in Merck in Q4 2014 and has held it in 41 quarters since.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Bontempo Ohly Capital Management's 13F filing for Q1 2026, filed 15 May 2026.